Healthpeak Properties, Inc. (NYSE:DOC) Receives $19.23 Consensus Target Price from Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have received a consensus recommendation of “Hold” from the fifteen analysts that are covering the stock, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $19.3846.

A number of research firms recently issued reports on DOC. Wells Fargo & Company boosted their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday. Robert W. Baird boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Morgan Stanley boosted their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 22nd. Scotiabank boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Finally, Royal Bank Of Canada boosted their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th.

Healthpeak Properties Stock Down 0.8%

Shares of NYSE DOC opened at $19.01 on Thursday. Healthpeak Properties has a one year low of $15.70 and a one year high of $20.27. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The business’s fifty day moving average price is $17.76 and its 200-day moving average price is $17.33. The stock has a market capitalization of $13.10 billion, a PE ratio of 59.40, a P/E/G ratio of 2.43 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same period in the previous year, the company posted $0.46 EPS. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities research analysts anticipate that Healthpeak Properties will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s payout ratio is presently 381.25%.

Insider Activity

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Institutional investors have recently added to or reduced their stakes in the business. Argent Advisors Inc. bought a new position in Healthpeak Properties in the 3rd quarter worth about $1,536,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Healthpeak Properties by 7.0% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust’s stock worth $37,063,000 after purchasing an additional 126,322 shares in the last quarter. Twin City Private Wealth LLC purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth about $1,148,000. JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Healthpeak Properties by 8.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 6,754,147 shares of the real estate investment trust’s stock worth $129,342,000 after buying an additional 525,875 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.